CLINICAL_TRIALS
trial_result
· 2019-04-22
Clinical Trial Update: Belimumab Impacting Transplant Eligibility [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating belimumab and its impact on transplant eligibility in renal transplant rejection patients; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: E. Steve Woodle | Conditions: Renal Transplant Rejection | Phase 1, Phase 2 | Status: COMPLETED